CIK 0001785530
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823523180
- Phone
- +1 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-24 | Atkins Michael B. Director | Grant or award · Stock Option (right to buy) | +6,723 | 6,723 | ||
| 2024-05-24 | Chatterjee Meeta Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2024-05-24 | Sherman Michael A. Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2024-05-24 | EVNIN LUKE Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2024-05-24 | Lazarus Alon Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2024-01-04 | Atkins Michael B. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-01-02 | Trost Timothy W. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-01-02 | Lubman Ellen Chief Business Officer | Grant or award · Stock Option (right to buy) | +131,900 | 131,900 | ||
| 2024-01-02 | Isaacs Randi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-01-02 | Karunatilake Chulani Chief Technology Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-01-02 | Seidel-Dugan Cynthia Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-01-02 | HICKLIN DANIEL J | Grant or award · Stock Option (right to buy) | +435,000 | 435,000 | ||
| 2023-06-21 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | −13,200 | 13,200 | ||
| 2023-06-21 | Morrison Briggs Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2023-06-21 | EVNIN LUKE Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2023-06-21 | Lazarus Alon Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2023-06-21 | DiRocco Derek Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2023-06-21 | Chatterjee Meeta Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2023-06-21 | Sherman Michael A. Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2023-01-06 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,853,000 | $2.21 | $4.1M | 5,701,056 |
Page 11 of 17 · 335 trades